Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
81 - 90 out of 509Page size: 10
  1. 2023
  2. Published

    HbA1c and beyond

    Rossing, Peter, 2023, In: Nephrology Dialysis Transplantation. 38, 1, p. 34-40 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?

    Rossing, Peter, Frimodt-Møller, M. & Persson, F., 2023, In: Seminars in Nephrology. 43, 3, 151430.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., Ahlers, C., Lage, A., Lawatscheck, R., Scalise, A. & Bakris, G. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2989-2998 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    on behalf of the FLOW Steering Committee and FLOW Trial Investigators, O. B. O. T. F. S. C. A. F. T. I., 2023, In: Nephrology Dialysis Transplantation. 38, 9, p. 2041-2051 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes

    Rotbain Curovic, V., Houlind, Morten Baltzer, Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Tavenier, J., Eugen-Olsen, J., Laverman, G. D., Kooy, A., Persson, F., Rossing, Peter & Heerspink, H. J. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 11, p. 3152-3160

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

    on the behalf of the PRIORITY Study Group, O. T. B. O. T. P. S. G., 2023, In: Journal of Diabetes and its Complications. 37, 4, 7 p., 108433.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study

    Ruilope, L. M., Pitt, B., Anker, S. D., Rossing, Peter, Kovesdy, C. P., Pecoits-Filho, R., Pergola, P., Joseph, A., Lage, A., Mentenich, N., Scheerer, M. F. & Bakris, G. L., 2023, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 38, 2, p. 372-383 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

    on behalf of the FIDELIO-DKD, O. B. O. T. F. & FIGARO DKD Investigators, F. D. I., 2023, In: Clinical Journal of the American Society of Nephrology. 18, 5, p. 602-612 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD

    Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Annals of Internal Medicine. 176, 1, p. 59-66 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., Davies, M., Edelman, S., Forst, T., Giorgino, F., Green, J., Groop, P. H., Hadjadj, S., J.L.Heerspink, H., Hompesch, M., Izthak, B., Ji, L., Kanumilli, N., Mankovsky, B., Mathieu, C. & 16 others, Miszon, M., Mustafa, R., Nauck, M., Pecoits-Filho, R., Pettus, J., Ranta, K., Rodbard, H. W., Rossing, Peter, Ryden, L., Schumm-Draeger, P. M., Solomon, S. D., Škrha, J., Topsever, P., Vilsbøll, Tina, Wilding, J. & Standl, E., 2023, In: Cardiovascular Diabetology. 22, 1, 59.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

Previous 1...5 6 7 8 9 10 11 12 ...51 Next

ID: 12937790